TITLE:
Evaluation of Liquid vs. Tablet Buprenorphine - 6

CONDITION:
Opioid-Related Disorders

INTERVENTION:
Buprenorphine

SUMMARY:

      The purpose of this study is to evaluate the steady-state pharmacokinetics and
      bioavailability of buprenorphine sublingual tablets vs. sublingual solution.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 21 Years to 50 Years
Criteria:

        Inclusion Criteria:

        M/F ages 21-50. Meet DSM-IV criteria for opioid dependence. Agree to conditions of the
        study and sign informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics.
        Acute hepatitis. Other medical condtions that deem participation to be unsafe.
      
